Rare diseases
Investigational molecules
Locations
66 Avenue Des Champs Elysees, 75008 Paris, France
Thiogenesis Therapeutics focuses on mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), a rare disorder at the intersection of neurology and metabolic disease. Its clinical research activity is centered on patient outcomes in this inherited condition.
The sponsor’s trial activity is directed toward therapeutic options for the neurological and systemic manifestations associated with mitochondrial disease.
Thiogenesis Therapeutics runs clinical trials in conditions such as MELAS syndrome, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
